| Application no. and date | 10781781.9 (espacenet) (Federated) (European Patent Register), 20101117 | | Patent/reg. no. and date | DK/EP 2501384, 20160217 | | Publication date | 20120926 | | Priority no. and date | US 261812 P, 20091117 | | EP pub. no. and date |
EP 2501384 20120926 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | 153171/BT/GP | | Inventor | GALLAGHER, Neil, Novartis Pharma AG
Postfach
CH-4002 Basel, CH,
YIN, Ophelia, 66 Henning Terrace
Denville
New Jersey 07834, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/506 (2006.01) , A61K 9/00 (2006.01) , A61P 35/00 (2006.01) , C07D 239/69 (2006.01) | | Title | Fremgangsmåde til behandling af proliferative lidelser og andre patologiske tilstande formidlede af BCR-ABL, C-KIT, DDR1, DDR2, eller PDGF-R-kinaseaktivitet | | Int. application no. | US2010056926 | | Int. publication no. | WO2011062927 | | Related patent (certificate) | | | Status | Ændret DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
